Back
SpartanNash 10K Form
Sell
27
SPTN
SpartanNash
Last Price:
22.72
Seasonality Move:
5.03%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-30 | 10Q | SPTN/SpartanNash Quarterly |
2023-11-09 | 10Q | SPTN/SpartanNash Quarterly |
2023-08-17 | 10Q | SPTN/SpartanNash Quarterly |
2023-06-01 | 10Q | SPTN/SpartanNash Quarterly |
2022-11-10 | 10Q | SPTN/SpartanNash Quarterly |
2022-08-18 | 10Q | SPTN/SpartanNash Quarterly |
Receive SPTN News And Ratings
See the #1 stock for the next 7 days that we like better than SPTN
SPTN Financial Statistics
Sales & Book Value
Annual Sales: | $9.73B |
---|---|
Cash Flow: | $68.72M |
Price / Cash Flow: | 16.58 |
Annual Sales: | $22.91 |
Price / Book: | 0.95 |
Profitability
EPS (TTM): | 1.33000 |
---|---|
Net Income (TTM): | $45.89M |
Gross Margin: | $1.49B |
Return on Equity: | 5.91% |
Return on Assets: | 1.96% |
SpartanNash Earnings Forecast
Key SpartanNash Financial Ratios
- The Gross Profit Margin over the past 27 years for SPTN is 15.27%.
- The Selling, General & Administrative Expenses for SPTN have been equal to 14.04% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 76.36% of Operating Income.
- The Net Earning history of SPTN is 0.54% of Total Revenues.
- Per Share Earnings over the last 27 years have been positive in 14 years.
SpartanNash Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Consumer Staples Distribution & Retail |
Sector: | Consumer Staples |
Current Symbol: | SPTN |
CUSIP: | 847215 |
Website: | spartannash.com |
Debt
Debt-to-Equity Ratio: | 0.77 |
---|---|
Current Ratio: | 1.62 |
Quick Ratio: | 0.7 |
Price-to-Earnings
Trailing P/E Ratio: | 14.54 |
---|---|
Forward P/E Ratio: | 10.48 |
SPTN Technical Analysis vs Fundamental Analysis
Sell
27
SpartanNash (SPTN)
is a Sell
Is SpartanNash a Buy or a Sell?
-
SpartanNash stock is rated a Sell
The current SpartanNash [SPTN] share price is $21.81. The Score for SPTN is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.